OLAPARIB 50 mg Logo (Lynparza 50 mg)
Generic Name: olaparib
Pill with imprint OLAPARIB 50 mg Logo is White, Capsule-shape and has been identified as Lynparza 50 mg. It is supplied by AstraZeneca Pharmaceuticals LP.
Lynparza is used in the treatment of ovarian cancer; prostate cancer; breast cancer, metastatic; pancreatic cancer and belongs to the drug class PARP inhibitors. There is positive evidence of human fetal risk during pregnancy. Lynparza 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OLAPARIB 50 mg Logo
Lynparza
- Generic Name
- olaparib
- Imprint
- OLAPARIB 50 mg Logo
- Strength
- 50 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Parp inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals LP
- National Drug Code (NDC)
- 00310-0657
More about Lynparza (olaparib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: PARP inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.